Sun Pharma's $11.75 Billion Acquisition of Organon: Implications and Insights
Morning Brief Podcast: Sun–Organon: The scope, risks, and future of India's biggest pharma deal
The Economic Times
Image: The Economic Times
Sun Pharma, India's largest drugmaker, has made headlines with its $11.75 billion acquisition of US-based Organon, marking the largest overseas purchase by an Indian company since 2007. This strategic move positions Sun Pharma among the top 25 global pharmaceutical firms, enhancing its capabilities in biosimilars and women's health.
- 01Sun Pharma's acquisition of Organon is valued at $11.75 billion.
- 02This deal is the largest overseas acquisition by an Indian company since Tata's acquisition of Corus in 2007.
- 03The acquisition doubles Sun Pharma's size and revenue to $12.4 billion.
- 04Sun Pharma gains a strong foothold in biosimilars and women's health.
- 05The company has $2.5 billion in pre-financing free cash flows to manage Organon's debt.
Advertisement
In-Article Ad
Sun Pharma, the largest pharmaceutical company in India, has announced its acquisition of US-based Organon for $11.75 billion, marking a significant milestone as the largest overseas purchase by an Indian firm since Tata's acquisition of Corus in 2007. This strategic acquisition effectively doubles Sun Pharma's size, elevating it to the ranks of the top 25 global pharmaceutical companies with a combined revenue of $12.4 billion. The deal provides Sun Pharma with an immediate foothold in the biosimilars market and strengthens its position in global women's health, alongside a portfolio of established brands across 150 countries. With $2.5 billion in combined pre-financing free cash flows, Sun Pharma is well-equipped to manage the debt associated with Organon, positioning itself for future growth in the competitive pharmaceutical landscape.
Advertisement
In-Article Ad
This acquisition could lead to increased investment in India's pharmaceutical sector, potentially creating jobs and enhancing research and development capabilities.
Advertisement
In-Article Ad
Reader Poll
What do you think about Indian companies making large overseas acquisitions?
Connecting to poll...
More about Sun Pharma
Read the original article
Visit the source for the complete story.